Get started
MYDECINE INNOVATIONS GROUP INC.MYDECINE INNOVATIONS GROUP INC.MYDECINE INNOVATIONS GROUP INC.

MYDECINE INNOVATIONS GROUP INC.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

MYCO chart

Key stats

Market capitalization
‪396.86 K‬CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.585CAD
Net income
‪−11.57 M‬CAD
Revenue
—
Shares float
‪24.76 M‬
Beta (1Y)
0.86

About MYDECINE INNOVATIONS GROUP INC.

Sector
Health Technology
CEO
David Joshua Bartch
Headquarters
Vancouver
Website
mydecine.com
Employees (FY)
3
Founded
2013
ISIN
CA62849F2008
FIGI
BBG006Z3G1J1
Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MYCO is 0.00 CAD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange MYDECINE INNOVATIONS GROUP INC. stocks are traded under the ticker MYCO.
MYDECINE INNOVATIONS GROUP INC. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
MYCO earnings for the last quarter are −0.35 CAD whereas the estimation was −1.00 CAD which accounts for 65.00% surprise. Estimated earnings for the next quarter are −1.00 CAD. See more details about MYDECINE INNOVATIONS GROUP INC. earnings.
MYDECINE INNOVATIONS GROUP INC. revenue for the last quarter amounts to 73.00 CAD despite the estimated figure of 0 CAD. In the next quarter revenue is expected to reach ‪300.00 K‬ CAD.
Yes, you can track MYDECINE INNOVATIONS GROUP INC. financials in yearly and quarterly reports right on TradingView.
Like other stocks, MYCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYDECINE INNOVATIONS GROUP INC. stock right from TradingView charts — choose your broker and connect to your account.
MYCO reached its all-time high on Jun 8, 2020 with the price of 1.15 CAD, and its all-time low was 0.00 CAD and was reached on Feb 6, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 3.00 employees. See our rating of the largest employees — is MYDECINE INNOVATIONS GROUP INC. on this list?